Clinical trial NCT05396664: Adolescent Transition West Africa
Official title: Adolescent Transition West Africa: An Outcome Evaluation of a Gender and Sexual and Reproductive Health and Rights Intervention in Mali, Burkina Faso, and Niger
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Adolescent Development
Lead sponsor: University of California, San Diego
Sponsor class: OTHER
Collaborators: name: Save the Children Netherlands
name: GRADE Africa
First posted: 2022-05-31
Enrollment: 4300
Sex: ALL
Minimum age (years): 10
Maximum age (years): 19
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: This trial will serve as an outcome evaluation of 'Adolescent Transition in West Africa' (ATWA), a school-based program in Mali, Burkina Faso, and Niger for adolescents ages 10-19. The overall objectives of the project are as follows: Impact: Improved sexual and reproductive health and rights of 472,180 adolescents. Outcome 1: Improved sexual and reproductive health and rights and gender equality knowledge, intent, and behaviors among 472,180 adolescents. Outcome 2: 500 health facilities offer quality adolescent responsive SRH services that are used by adolescent girls and boys. To evaluate program impact, an external evaluation will be conducted. A pre/post cross-sectional evaluation design will be used across two evaluation years.


Eligibility criteria: Inclusion Criteria:

* Enrolled in primary or secondary school
* Participating in community group (Niger only)
* Aged 10 to 19

Exclusion Criteria:

* Not enrolled in school (Mali and Burkina Faso)
* Younger than age 10
* Older than age 19

Primary outcomes:
measure: Impact Indicator 1. Decrease in adolescent birth rate
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Impact 2. Decrease in proportion of adolescents who have ever been pregnant or caused a pregnancy
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Impact 3. Increase in need for family planning satisfied with modern contraception
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Impact 4. Increase in adolescent modern contraceptive prevalence rate
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Impact 5. Decrease in proportion of adolescents married
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.1.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.2.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.3.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.4.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.5.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.6.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.7.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.8.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.9.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.10.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Outcome 1.11.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Output 1.2.1.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Output 1.2.2.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
measure: Output 1.2.3.
timeFrame: Year 1 Evaluation: September 2021 - May 2022; Year 2 Evaluation: September 2022 - May 2023
Secondary outcomes:
Other outcomes:
Locations:
city: Ouagadougou
country: Burkina Faso
facility: Save the Children, Burkina Faso
city: Bamako
country: Mali
facility: Save the Children, Mali
city: Niamey
country: Niger
facility: Save the Children, Niger
Study officials:
affiliation: University of California, San Diego
name: Jay Silverman, PhD
role: PRINCIPAL_INVESTIGATOR
References: